+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Pyrogen Testing Market - Global Forecast 2026-2032- Product Image
Pyrogen Testing Market - Global Forecast 2026-2032- Product Image
Sale

Pyrogen Testing Market - Global Forecast 2026-2032

  • Report

  • 183 Pages
  • August 2026
  • Region: Global
  • 360iResearch™
  • ID: 4968889
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Pyrogen Testing Market is projected to reach USD 1.07 Billion in 2026. It is expected to continue growing at a CAGR of 10.42%, reaching USD 1.96 Billion by 2032.

Pyrogen testing is a critical quality-control requirement for injectable drugs, biologics, vaccines, implantable medical devices, dialysis products, and other sterile healthcare products that can introduce fever-inducing contaminants into the bloodstream. The discipline is anchored in recognized compendial and regulatory frameworks, including USP < 85> for bacterial endotoxins, USP < 151> for rabbit pyrogen testing, European Pharmacopoeia 2.6.14 for bacterial endotoxins, European Pharmacopoeia 2.6.30 for monocyte activation testing, and FDA expectations for parenteral product safety.

The market is being shaped by rising biologics production, expanding injectable therapies, growth in cell and gene therapy manufacturing, and stronger demand for validated, rapid, and animal-alternative pyrogen detection. Keywords defining the competitive landscape include pyrogen testing market, bacterial endotoxin testing, LAL assay, recombinant Factor C testing, monocyte activation test, sterility assurance, pharmaceutical quality control, and medical device biocompatibility testing.

Transformative Shifts in Pyrogen Testing

The pyrogen testing landscape is shifting from traditional endpoint assays toward faster, more sustainable, and data-rich quality-control platforms. Limulus Amebocyte Lysate testing remains widely used for bacterial endotoxin detection, but the industry is increasing adoption of recombinant Factor C and monocyte activation test methods as manufacturers respond to supply-chain resilience, animal welfare, and broader pyrogen-detection needs.

Regulators and standards bodies are also influencing transformation. The European Pharmacopoeia has recognized non-animal alternatives, and global manufacturers are strengthening method validation, endotoxin masking assessments, low-endotoxin recovery studies, and contamination-control strategies. As sterile manufacturing becomes more complex, pyrogen testing is evolving from a release-test checkpoint into an integrated element of pharmaceutical quality systems.

Cumulative Impact of Artificial Intelligence on Pyrogen Testing

Artificial intelligence is beginning to reshape pyrogen testing by improving data review, assay trend analysis, deviation detection, and predictive quality management. In validated laboratory environments, AI-enabled analytics can help identify shifts in endotoxin recovery, flag atypical kinetic curves in LAL assays, and support faster investigation of out-of-specification or out-of-trend results.

AI is also strengthening laboratory informatics through integration with LIMS, electronic batch records, environmental monitoring data, and manufacturing execution systems. While AI does not replace validated compendial methods or qualified analysts, it supports faster decision-making, improved data integrity, and proactive contamination control when implemented under Good Manufacturing Practice, 21 CFR Part 11, EU GMP Annex 11, and applicable computerized system validation expectations.

Key Regional Insights Across the Pyrogen Testing Market

Asia-Pacific is gaining strategic importance as China, India, Japan, South Korea, Singapore, and Australia expand biologics, biosimilars, vaccines, and injectable manufacturing capacity. Regional demand is reinforced by contract development and manufacturing organization growth, increasing regulatory alignment with ICH quality guidelines, and investment in high-throughput quality-control laboratories.

North America remains a mature hub for pyrogen testing, led by the United States and Canada, where FDA-regulated biologics, advanced therapies, medical devices, and pharmaceutical outsourcing sustain demand for validated endotoxin and pyrogen methods. Europe continues to influence global practice through the European Pharmacopoeia, EDQM initiatives, EMA expectations, and strong adoption of animal-alternative methods.

Latin America, including Brazil and Mexico, is expanding quality infrastructure for sterile medicines and vaccines, while the Middle East is building pharmaceutical manufacturing and healthcare self-sufficiency through GCC investment programs. Africa is an emerging opportunity, supported by vaccine localization, public-health procurement, and gradual strengthening of national regulatory systems.

Key Group Insights Shaping Pyrogen Testing Demand

ASEAN is becoming a high-growth cluster for pharmaceutical manufacturing, with Singapore, Malaysia, Thailand, Indonesia, Vietnam, and the Philippines supporting demand for endotoxin testing, sterility assurance, and outsourced laboratory services. Harmonization efforts and multinational investment are improving regional quality-control capabilities.

The GCC is prioritizing healthcare security and local drug manufacturing, creating opportunities for pyrogen testing suppliers that can support GMP-compliant validation and rapid release testing. The European Union remains a benchmark market because of its strong pharmacopoeial framework, regulatory emphasis on animal-alternative science, and advanced biologics ecosystem.

BRICS economies are shaping volume-led demand through expanding vaccine, biosimilar, and injectable drug production. G7 countries continue to set high standards for advanced therapy manufacturing, data integrity, and laboratory automation. NATO-aligned markets also show consistent demand because medical readiness, vaccine stockpiles, and sterile injectable supply chains require reliable pyrogen-control systems.

Key Country Insights for Pyrogen Testing Adoption

The United States leads adoption through FDA-regulated biologics, injectable drugs, medical devices, and advanced therapies, while Canada supports demand through GMP manufacturing and clinical research infrastructure. Mexico is strengthening sterile manufacturing and nearshoring opportunities, and Brazil remains Latin America's largest pharmaceutical market with expanding biologics and vaccine capacity.

In Europe, the United Kingdom, Germany, France, Italy, and Spain maintain strong demand through established pharmaceutical production, contract testing, and medical technology sectors. Germany and France are especially influential in biologics and quality systems, while the United Kingdom supports innovation in cell and gene therapy. Russia retains domestic demand for vaccines and sterile drugs, although market access is influenced by geopolitical and supply-chain constraints.

China and India are central to global volume growth due to large-scale API, injectable, vaccine, biosimilar, and CDMO capacity. Japan emphasizes high-quality manufacturing and regulatory precision, South Korea is expanding biologics and biosimilars, and Australia supports demand through clinical trials, biomedical research, and regulated sterile-product testing.

Actionable Recommendations for Industry Leaders

Industry leaders should prioritize a balanced method strategy that includes bacterial endotoxin testing, recombinant Factor C where validated, and monocyte activation testing for products requiring broader pyrogen detection. Method selection should be based on product characteristics, regulatory filing strategy, compendial acceptance, interference testing, and lifecycle validation.

Companies should invest in laboratory automation, LIMS integration, analyst training, supplier qualification, and contamination-control programs that connect raw materials, water systems, cleanrooms, and final product release. Building early dialogue with regulators, documenting method comparability, and preparing robust data-integrity controls will help reduce approval risk and improve batch-release reliability.

Research Methodology

This executive summary is based on secondary research from recognized regulatory, compendial, scientific, and industry sources, including USP, European Pharmacopoeia, EDQM, FDA guidance, EMA quality expectations, ICH guidelines, WHO technical materials, and publicly available information from pharmaceutical quality-control stakeholders.

The analysis applies triangulation across regulatory requirements, manufacturing trends, technology adoption, regional pharmaceutical investment, and sterile-product quality needs. Insights are framed to support SEO visibility for pyrogen testing, endotoxin testing, LAL assay, recombinant Factor C, monocyte activation test, pharmaceutical QC, and sterile manufacturing without relying on unverified market-size claims.

Conclusion: Future Outlook for Pyrogen Testing

Pyrogen testing is moving into a more advanced phase defined by validated alternative methods, automation, sustainability, and stronger integration with pharmaceutical quality systems. The market's long-term relevance is supported by the non-negotiable need to protect patients from fever-inducing contaminants in parenteral medicines, biologics, vaccines, and medical devices.

Organizations that combine regulatory compliance with scientific modernization will be best positioned to compete. The future of pyrogen testing will favor companies that can deliver accurate endotoxin detection, broader pyrogen coverage, digital traceability, rapid turnaround, and globally harmonized validation strategies.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. New Revenue Opportunities
3.5. Next-Generation Business Models
3.6. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Pyrogen Testing Market, by Product Type
7.1. Introduction
7.2. Instruments
7.2.1. Automated Systems
7.2.2. Incubators
7.2.3. LAL Analyzers
7.3. Kits
7.3.1. Chromogenic
7.3.2. Gel Clot
7.3.3. Turbidimetric
7.4. Reagents
7.4.1. Controls
7.4.2. LAL Reagents
7.4.3. RFC Reagents
7.5. Services
7.5.1. Consulting Services
7.5.2. Testing Services
8. Pyrogen Testing Market, by Test Method
8.1. Introduction
8.2. Limulus Amebocyte Lysate
8.2.1. Chromogenic
8.2.2. Gel Clot
8.2.3. Turbidimetric
8.3. Monocyte Activation Test
8.4. Recombinant Factor C Assay
9. Pyrogen Testing Market, by Pyrogen Type
9.1. Introduction
9.2. Bacterial Endotoxin
9.3. Non-Endotoxin Pyrogens
9.3.1. Fungal Pyrogens
9.3.2. Mycoplasma Pyrogens
9.3.3. Viral Pyrogens
10. Pyrogen Testing Market, by End User
10.1. Introduction
10.2. Academic & Research Institutes
10.3. Biotechnology Companies
10.4. Contract Research Organizations
10.5. Hospitals & Clinics
10.6. Pharmaceutical Manufacturers
11. Pyrogen Testing Market, by Application
11.1. Introduction
11.2. Clinical Diagnostics
11.3. Drug Development
11.4. Quality Control
11.5. Research
12. Pyrogen Testing Market, by Region
12.1. Asia-Pacific
12.2. North America
12.3. Latin America
12.4. Europe
12.5. Middle East
12.6. Africa
13. Pyrogen Testing Market, by Group
13.1. ASEAN
13.2. GCC
13.3. European Union
13.4. BRICS
13.5. G7
13.6. NATO
14. Pyrogen Testing Market, by Country
14.1. United States
14.2. Canada
14.3. Mexico
14.4. Brazil
14.5. United Kingdom
14.6. Germany
14.7. France
14.8. Russia
14.9. Italy
14.10. Spain
14.11. China
14.12. India
14.13. Japan
14.14. Australia
14.15. South Korea
15. Competitive Landscape
15.1. Market Share Analysis, 2025
15.2. FPNV Positioning Matrix, 2025
15.3. Market Concentration Analysis, 2025
15.3.1. Concentration Ratio (CR)
15.3.2. Herfindahl Hirschman Index (HHI)
15.4. Recent Developments & Impact Analysis, 2025
15.5. Product Portfolio Analysis, 2025
15.6. Benchmarking Analysis, 2025
16. Company Profiles
16.1. BioMérieux SA
16.2. BMG LABTECH GmbH
16.3. Cambrex Corporation
16.4. Charles River Laboratories International, Inc.
16.5. Ellab A/S
16.6. Eurofins Scientific SE
16.7. Fujifilm Wako Pure Chemical Corporation
16.8. GenScript Biotech Corporation
16.9. Lonza Group AG
16.10. MAT BioTech BV
16.11. Merck KGaA
16.12. Microcoat Biotechnologie GmbH
16.13. Minerva Analytix GmbH
16.14. Nelson Laboratories LLC
16.15. Pacific BioLabs, Inc.
16.16. Sanquin Reagents B.V.
16.17. Sartorius AG
16.18. Seikagaku Corporation
16.19. Thermo Fisher Scientific Inc.
16.20. WuXi AppTec Co., Ltd.
16.21. Xiamen Bioendo Technology Co., Ltd.
List of Figures
FIGURE 1. GLOBAL PYROGEN TESTING MARKET, YEARS CONSIDERED FOR THE STUDY
FIGURE 2. GLOBAL PYROGEN TESTING MARKET, RESEARCH DESIGN
FIGURE 3. GLOBAL PYROGEN TESTING MARKET, RESEARCH FRAMEWORK
FIGURE 4. GLOBAL PYROGEN TESTING MARKET, DATA TRIANGULATION
FIGURE 5. GLOBAL PYROGEN TESTING MARKET SIZE, 2024-2032 (USD MILLION)
FIGURE 6. GLOBAL PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2032 (%)
FIGURE 7. GLOBAL PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL PYROGEN TESTING MARKET SIZE, BY TEST METHOD, 2025 VS 2032 (%)
FIGURE 9. GLOBAL PYROGEN TESTING MARKET SIZE, BY TEST METHOD, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL PYROGEN TESTING MARKET SIZE, BY PYROGEN TYPE, 2025 VS 2032 (%)
FIGURE 11. GLOBAL PYROGEN TESTING MARKET SIZE, BY PYROGEN TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. GLOBAL PYROGEN TESTING MARKET SIZE, BY END USER, 2025 VS 2032 (%)
FIGURE 13. GLOBAL PYROGEN TESTING MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 14. GLOBAL PYROGEN TESTING MARKET SIZE, BY APPLICATION, 2025 VS 2032 (%)
FIGURE 15. GLOBAL PYROGEN TESTING MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 16. GLOBAL PYROGEN TESTING MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 17. GLOBAL PYROGEN TESTING MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 18. GLOBAL PYROGEN TESTING MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 19. GLOBAL PYROGEN TESTING MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 20. GLOBAL PYROGEN TESTING MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
FIGURE 21. GLOBAL PYROGEN TESTING MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 22. GLOBAL PYROGEN TESTING MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 23. GLOBAL PYROGEN TESTING MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025
List of Tables
TABLE 1. GLOBAL PYROGEN TESTING MARKET SEGMENTATION & COVERAGE
TABLE 2. GLOBAL PYROGEN TESTING MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 3. GLOBAL PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 4. GLOBAL INSTRUMENTS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 5. GLOBAL INSTRUMENTS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 6. GLOBAL INSTRUMENTS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 7. GLOBAL AUTOMATED SYSTEMS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 8. GLOBAL AUTOMATED SYSTEMS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 9. GLOBAL AUTOMATED SYSTEMS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 10. GLOBAL INCUBATORS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 11. GLOBAL INCUBATORS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 12. GLOBAL INCUBATORS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 13. GLOBAL LAL ANALYZERS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 14. GLOBAL LAL ANALYZERS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 15. GLOBAL LAL ANALYZERS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 16. GLOBAL KITS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 17. GLOBAL KITS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 18. GLOBAL KITS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 19. GLOBAL CHROMOGENIC MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 20. GLOBAL CHROMOGENIC MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 21. GLOBAL CHROMOGENIC MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 22. GLOBAL GEL CLOT MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 23. GLOBAL GEL CLOT MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 24. GLOBAL GEL CLOT MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 25. GLOBAL TURBIDIMETRIC MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 26. GLOBAL TURBIDIMETRIC MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 27. GLOBAL TURBIDIMETRIC MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 28. GLOBAL REAGENTS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 29. GLOBAL REAGENTS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 30. GLOBAL REAGENTS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 31. GLOBAL CONTROLS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 32. GLOBAL CONTROLS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 33. GLOBAL CONTROLS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 34. GLOBAL LAL REAGENTS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 35. GLOBAL LAL REAGENTS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 36. GLOBAL LAL REAGENTS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 37. GLOBAL RFC REAGENTS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 38. GLOBAL RFC REAGENTS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 39. GLOBAL RFC REAGENTS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 40. GLOBAL SERVICES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 41. GLOBAL SERVICES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 42. GLOBAL SERVICES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 43. GLOBAL CONSULTING SERVICES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 44. GLOBAL CONSULTING SERVICES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 45. GLOBAL CONSULTING SERVICES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 46. GLOBAL TESTING SERVICES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 47. GLOBAL TESTING SERVICES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 48. GLOBAL TESTING SERVICES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 49. GLOBAL PYROGEN TESTING MARKET SIZE, BY TEST METHOD, 2017-2032 (USD MILLION)
TABLE 50. GLOBAL LIMULUS AMEBOCYTE LYSATE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 51. GLOBAL LIMULUS AMEBOCYTE LYSATE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 52. GLOBAL LIMULUS AMEBOCYTE LYSATE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 53. GLOBAL CHROMOGENIC MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 54. GLOBAL CHROMOGENIC MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 55. GLOBAL CHROMOGENIC MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 56. GLOBAL GEL CLOT MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 57. GLOBAL GEL CLOT MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 58. GLOBAL GEL CLOT MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 59. GLOBAL TURBIDIMETRIC MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 60. GLOBAL TURBIDIMETRIC MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 61. GLOBAL TURBIDIMETRIC MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 62. GLOBAL MONOCYTE ACTIVATION TEST MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 63. GLOBAL MONOCYTE ACTIVATION TEST MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 64. GLOBAL MONOCYTE ACTIVATION TEST MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 65. GLOBAL RECOMBINANT FACTOR C ASSAY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 66. GLOBAL RECOMBINANT FACTOR C ASSAY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 67. GLOBAL RECOMBINANT FACTOR C ASSAY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 68. GLOBAL PYROGEN TESTING MARKET SIZE, BY PYROGEN TYPE, 2017-2032 (USD MILLION)
TABLE 69. GLOBAL BACTERIAL ENDOTOXIN MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 70. GLOBAL BACTERIAL ENDOTOXIN MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 71. GLOBAL BACTERIAL ENDOTOXIN MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 72. GLOBAL NON-ENDOTOXIN PYROGENS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 73. GLOBAL NON-ENDOTOXIN PYROGENS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 74. GLOBAL NON-ENDOTOXIN PYROGENS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 75. GLOBAL FUNGAL PYROGENS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 76. GLOBAL FUNGAL PYROGENS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 77. GLOBAL FUNGAL PYROGENS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 78. GLOBAL MYCOPLASMA PYROGENS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 79. GLOBAL MYCOPLASMA PYROGENS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 80. GLOBAL MYCOPLASMA PYROGENS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 81. GLOBAL VIRAL PYROGENS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 82. GLOBAL VIRAL PYROGENS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 83. GLOBAL VIRAL PYROGENS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 84. GLOBAL PYROGEN TESTING MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 85. GLOBAL ACADEMIC & RESEARCH INSTITUTES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 86. GLOBAL ACADEMIC & RESEARCH INSTITUTES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 87. GLOBAL ACADEMIC & RESEARCH INSTITUTES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 88. GLOBAL BIOTECHNOLOGY COMPANIES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 89. GLOBAL BIOTECHNOLOGY COMPANIES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 90. GLOBAL BIOTECHNOLOGY COMPANIES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 91. GLOBAL CONTRACT RESEARCH ORGANIZATIONS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 92. GLOBAL CONTRACT RESEARCH ORGANIZATIONS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 93. GLOBAL CONTRACT RESEARCH ORGANIZATIONS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 94. GLOBAL HOSPITALS & CLINICS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 95. GLOBAL HOSPITALS & CLINICS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 96. GLOBAL HOSPITALS & CLINICS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 97. GLOBAL PHARMACEUTICAL MANUFACTURERS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 98. GLOBAL PHARMACEUTICAL MANUFACTURERS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 99. GLOBAL PHARMACEUTICAL MANUFACTURERS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 100. GLOBAL PYROGEN TESTING MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 101. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 102. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 103. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 104. GLOBAL DRUG DEVELOPMENT MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 105. GLOBAL DRUG DEVELOPMENT MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 106. GLOBAL DRUG DEVELOPMENT MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 107. GLOBAL QUALITY CONTROL MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 108. GLOBAL QUALITY CONTROL MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 109. GLOBAL QUALITY CONTROL MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 110. GLOBAL RESEARCH MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 111. GLOBAL RESEARCH MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 112. GLOBAL RESEARCH MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 113. GLOBAL PYROGEN TESTING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 114. ASIA-PACIFIC PYROGEN TESTING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 115. ASIA-PACIFIC PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 116. ASIA-PACIFIC PYROGEN TESTING MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 117. ASIA-PACIFIC PYROGEN TESTING MARKET SIZE, BY KITS, 2017-2032 (USD MILLION)
TABLE 118. ASIA-PACIFIC PYROGEN TESTING MARKET SIZE, BY REAGENTS, 2017-2032 (USD MILLION)
TABLE 119. ASIA-PACIFIC PYROGEN TESTING MARKET SIZE, BY SERVICES, 2017-2032 (USD MILLION)
TABLE 120. ASIA-PACIFIC PYROGEN TESTING MARKET SIZE, BY TEST METHOD, 2017-2032 (USD MILLION)
TABLE 121. ASIA-PACIFIC PYROGEN TESTING MARKET SIZE, BY LIMULUS AMEBOCYTE LYSATE, 2017-2032 (USD MILLION)
TABLE 122. ASIA-PACIFIC PYROGEN TESTING MARKET SIZE, BY PYROGEN TYPE, 2017-2032 (USD MILLION)
TABLE 123. ASIA-PACIFIC PYROGEN TESTING MARKET SIZE, BY NON-ENDOTOXIN PYROGENS, 2017-2032 (USD MILLION)
TABLE 124. ASIA-PACIFIC PYROGEN TESTING MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 125. ASIA-PACIFIC PYROGEN TESTING MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 126. NORTH AMERICA PYROGEN TESTING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 127. NORTH AMERICA PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 128. NORTH AMERICA PYROGEN TESTING MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 129. NORTH AMERICA PYROGEN TESTING MARKET SIZE, BY KITS, 2017-2032 (USD MILLION)
TABLE 130. NORTH AMERICA PYROGEN TESTING MARKET SIZE, BY REAGENTS, 2017-2032 (USD MILLION)
TABLE 131. NORTH AMERICA PYROGEN TESTING MARKET SIZE, BY SERVICES, 2017-2032 (USD MILLION)
TABLE 132. NORTH AMERICA PYROGEN TESTING MARKET SIZE, BY TEST METHOD, 2017-2032 (USD MILLION)
TABLE 133. NORTH AMERICA PYROGEN TESTING MARKET SIZE, BY LIMULUS AMEBOCYTE LYSATE, 2017-2032 (USD MILLION)
TABLE 134. NORTH AMERICA PYROGEN TESTING MARKET SIZE, BY PYROGEN TYPE, 2017-2032 (USD MILLION)
TABLE 135. NORTH AMERICA PYROGEN TESTING MARKET SIZE, BY NON-ENDOTOXIN PYROGENS, 2017-2032 (USD MILLION)
TABLE 136. NORTH AMERICA PYROGEN TESTING MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 137. NORTH AMERICA PYROGEN TESTING MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 138. LATIN AMERICA PYROGEN TESTING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 139. LATIN AMERICA PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 140. LATIN AMERICA PYROGEN TESTING MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 141. LATIN AMERICA PYROGEN TESTING MARKET SIZE, BY KITS, 2017-2032 (USD MILLION)
TABLE 142. LATIN AMERICA PYROGEN TESTING MARKET SIZE, BY REAGENTS, 2017-2032 (USD MILLION)
TABLE 143. LATIN AMERICA PYROGEN TESTING MARKET SIZE, BY SERVICES, 2017-2032 (USD MILLION)
TABLE 144. LATIN AMERICA PYROGEN TESTING MARKET SIZE, BY TEST METHOD, 2017-2032 (USD MILLION)
TABLE 145. LATIN AMERICA PYROGEN TESTING MARKET SIZE, BY LIMULUS AMEBOCYTE LYSATE, 2017-2032 (USD MILLION)
TABLE 146. LATIN AMERICA PYROGEN TESTING MARKET SIZE, BY PYROGEN TYPE, 2017-2032 (USD MILLION)
TABLE 147. LATIN AMERICA PYROGEN TESTING MARKET SIZE, BY NON-ENDOTOXIN PYROGENS, 2017-2032 (USD MILLION)
TABLE 148. LATIN AMERICA PYROGEN TESTING MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 149. LATIN AMERICA PYROGEN TESTING MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 150. EUROPE PYROGEN TESTING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 151. EUROPE PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 152. EUROPE PYROGEN TESTING MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 153. EUROPE PYROGEN TESTING MARKET SIZE, BY KITS, 2017-2032 (USD MILLION)
TABLE 154. EUROPE PYROGEN TESTING MARKET SIZE, BY REAGENTS, 2017-2032 (USD MILLION)
TABLE 155. EUROPE PYROGEN TESTING MARKET SIZE, BY SERVICES, 2017-2032 (USD MILLION)
TABLE 156. EUROPE PYROGEN TESTING MARKET SIZE, BY TEST METHOD, 2017-2032 (USD MILLION)
TABLE 157. EUROPE PYROGEN TESTING MARKET SIZE, BY LIMULUS AMEBOCYTE LYSATE, 2017-2032 (USD MILLION)
TABLE 158. EUROPE PYROGEN TESTING MARKET SIZE, BY PYROGEN TYPE, 2017-2032 (USD MILLION)
TABLE 159. EUROPE PYROGEN TESTING MARKET SIZE, BY NON-ENDOTOXIN PYROGENS, 2017-2032 (USD MILLION)
TABLE 160. EUROPE PYROGEN TESTING MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 161. EUROPE PYROGEN TESTING MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 162. MIDDLE EAST PYROGEN TESTING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 163. MIDDLE EAST PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 164. MIDDLE EAST PYROGEN TESTING MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 165. MIDDLE EAST PYROGEN TESTING MARKET SIZE, BY KITS, 2017-2032 (USD MILLION)
TABLE 166. MIDDLE EAST PYROGEN TESTING MARKET SIZE, BY REAGENTS, 2017-2032 (USD MILLION)
TABLE 167. MIDDLE EAST PYROGEN TESTING MARKET SIZE, BY SERVICES, 2017-2032 (USD MILLION)
TABLE 168. MIDDLE EAST PYROGEN TESTING MARKET SIZE, BY TEST METHOD, 2017-2032 (USD MILLION)
TABLE 169. MIDDLE EAST PYROGEN TESTING MARKET SIZE, BY LIMULUS AMEBOCYTE LYSATE, 2017-2032 (USD MILLION)
TABLE 170. MIDDLE EAST PYROGEN TESTING MARKET SIZE, BY PYROGEN TYPE, 2017-2032 (USD MILLION)
TABLE 171. MIDDLE EAST PYROGEN TESTING MARKET SIZE, BY NON-ENDOTOXIN PYROGENS, 2017-2032 (USD MILLION)
TABLE 172. MIDDLE EAST PYROGEN TESTING MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 173. MIDDLE EAST PYROGEN TESTING MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 174. AFRICA PYROGEN TESTING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 175. AFRICA PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 176. AFRICA PYROGEN TESTING MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 177. AFRICA PYROGEN TESTING MARKET SIZE, BY KITS, 2017-2032 (USD MILLION)
TABLE 178. AFRICA PYROGEN TESTING MARKET SIZE, BY REAGENTS, 2017-2032 (USD MILLION)
TABLE 179. AFRICA PYROGEN TESTING MARKET SIZE, BY SERVICES, 2017-2032 (USD MILLION)
TABLE 180. AFRICA PYROGEN TESTING MARKET SIZE, BY TEST METHOD, 2017-2032 (USD MILLION)
TABLE 181. AFRICA PYROGEN TESTING MARKET SIZE, BY LIMULUS AMEBOCYTE LYSATE, 2017-2032 (USD MILLION)
TABLE 182. AFRICA PYROGEN TESTING MARKET SIZE, BY PYROGEN TYPE, 2017-2032 (USD MILLION)
TABLE 183. AFRICA PYROGEN TESTING MARKET SIZE, BY NON-ENDOTOXIN PYROGENS, 2017-2032 (USD MILLION)
TABLE 184. AFRICA PYROGEN TESTING MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 185. AFRICA PYROGEN TESTING MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 186. GLOBAL PYROGEN TESTING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 187. ASEAN PYROGEN TESTING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 188. ASEAN PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 189. ASEAN PYROGEN TESTING MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 190. ASEAN PYROGEN TESTING MARKET SIZE, BY KITS, 2017-2032 (USD MILLION)
TABLE 191. ASEAN PYROGEN TESTING MARKET SIZE, BY REAGENTS, 2017-2032 (USD MILLION)
TABLE 192. ASEAN PYROGEN TESTING MARKET SIZE, BY SERVICES, 2017-2032 (USD MILLION)
TABLE 193. ASEAN PYROGEN TESTING MARKET SIZE, BY TEST METHOD, 2017-2032 (USD MILLION)
TABLE 194. ASEAN PYROGEN TESTING MARKET SIZE, BY LIMULUS AMEBOCYTE LYSATE, 2017-2032 (USD MILLION)
TABLE 195. ASEAN PYROGEN TESTING MARKET SIZE, BY PYROGEN TYPE, 2017-2032 (USD MILLION)
TABLE 196. ASEAN PYROGEN TESTING MARKET SIZE, BY NON-ENDOTOXIN PYROGENS, 2017-2032 (USD MILLION)
TABLE 197. ASEAN PYROGEN TESTING MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 198. ASEAN PYROGEN TESTING MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 199. GCC PYROGEN TESTING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 200. GCC PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 201. GCC PYROGEN TESTING MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 202. GCC PYROGEN TESTING MARKET SIZE, BY KITS, 2017-2032 (USD MILLION)
TABLE 203. GCC PYROGEN TESTING MARKET SIZE, BY REAGENTS, 2017-2032 (USD MILLION)
TABLE 204. GCC PYROGEN TESTING MARKET SIZE, BY SERVICES, 2017-2032 (USD MILLION)
TABLE 205. GCC PYROGEN TESTING MARKET SIZE, BY TEST METHOD, 2017-2032 (USD MILLION)
TABLE 206. GCC PYROGEN TESTING MARKET SIZE, BY LIMULUS AMEBOCYTE LYSATE, 2017-2032 (USD MILLION)
TABLE 207. GCC PYROGEN TESTING MARKET SIZE, BY PYROGEN TYPE, 2017-2032 (USD MILLION)
TABLE 208. GCC PYROGEN TESTING MARKET SIZE, BY NON-ENDOTOXIN PYROGENS, 2017-2032 (USD MILLION)
TABLE 209. GCC PYROGEN TESTING MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 210. GCC PYROGEN TESTING MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 211. EUROPEAN UNION PYROGEN TESTING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 212. EUROPEAN UNION PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 213. EUROPEAN UNION PYROGEN TESTING MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 214. EUROPEAN UNION PYROGEN TESTING MARKET SIZE, BY KITS, 2017-2032 (USD MILLION)
TABLE 215. EUROPEAN UNION PYROGEN TESTING MARKET SIZE, BY REAGENTS, 2017-2032 (USD MILLION)
TABLE 216. EUROPEAN UNION PYROGEN TESTING MARKET SIZE, BY SERVICES, 2017-2032 (USD MILLION)
TABLE 217. EUROPEAN UNION PYROGEN TESTING MARKET SIZE, BY TEST METHOD, 2017-2032 (USD MILLION)
TABLE 218. EUROPEAN UNION PYROGEN TESTING MARKET SIZE, BY LIMULUS AMEBOCYTE LYSATE, 2017-2032 (USD MILLION)
TABLE 219. EUROPEAN UNION PYROGEN TESTING MARKET SIZE, BY PYROGEN TYPE, 2017-2032 (USD MILLION)
TABLE 220. EUROPEAN UNION PYROGEN TESTING MARKET SIZE, BY NON-ENDOTOXIN PYROGENS, 2017-2032 (USD MILLION)
TABLE 221. EUROPEAN UNION PYROGEN TESTING MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 222. EUROPEAN UNION PYROGEN TESTING MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 223. BRICS PYROGEN TESTING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 224. BRICS PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 225. BRICS PYROGEN TESTING MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 226. BRICS PYROGEN TESTING MARKET SIZE, BY KITS, 2017-2032 (USD MILLION)
TABLE 227. BRICS PYROGEN TESTING MARKET SIZE, BY REAGENTS, 2017-2032 (USD MILLION)
TABLE 228. BRICS PYROGEN TESTING MARKET SIZE, BY SERVICES, 2017-2032 (USD MILLION)
TABLE 229. BRICS PYROGEN TESTING MARKET SIZE, BY TEST METHOD, 2017-2032 (USD MILLION)
TABLE 230. BRICS PYROGEN TESTING MARKET SIZE, BY LIMULUS AMEBOCYTE LYSATE, 2017-2032 (USD MILLION)
TABLE 231. BRICS PYROGEN TESTING MARKET SIZE, BY PYROGEN TYPE, 2017-2032 (USD MILLION)
TABLE 232. BRICS PYROGEN TESTING MARKET SIZE, BY NON-ENDOTOXIN PYROGENS, 2017-2032 (USD MILLION)
TABLE 233. BRICS PYROGEN TESTING MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 234. BRICS PYROGEN TESTING MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 235. G7 PYROGEN TESTING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 236. G7 PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 237. G7 PYROGEN TESTING MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 238. G7 PYROGEN TESTING MARKET SIZE, BY KITS, 2017-2032 (USD MILLION)
TABLE 239. G7 PYROGEN TESTING MARKET SIZE, BY REAGENTS, 2017-2032 (USD MILLION)
TABLE 240. G7 PYROGEN TESTING MARKET SIZE, BY SERVICES, 2017-2032 (USD MILLION)
TABLE 241. G7 PYROGEN TESTING MARKET SIZE, BY TEST METHOD, 2017-2032 (USD MILLION)
TABLE 242. G7 PYROGEN TESTING MARKET SIZE, BY LIMULUS AMEBOCYTE LYSATE, 2017-2032 (USD MILLION)
TABLE 243. G7 PYROGEN TESTING MARKET SIZE, BY PYROGEN TYPE, 2017-2032 (USD MILLION)
TABLE 244. G7 PYROGEN TESTING MARKET SIZE, BY NON-ENDOTOXIN PYROGENS, 2017-2032 (USD MILLION)
TABLE 245. G7 PYROGEN TESTING MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 246. G7 PYROGEN TESTING MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 247. NATO PYROGEN TESTING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 248. NATO PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 249. NATO PYROGEN TESTING MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 250. NATO PYROGEN TESTING MARKET SIZE, BY KITS, 2017-2032 (USD MILLION)
TABLE 251. NATO PYROGEN TESTING MARKET SIZE, BY REAGENTS, 2017-2032 (USD MILLION)
TABLE 252. NATO PYROGEN TESTING MARKET SIZE, BY SERVICES, 2017-2032 (USD MILLION)
TABLE 253. NATO PYROGEN TESTING MARKET SIZE, BY TEST METHOD, 2017-2032 (USD MILLION)
TABLE 254. NATO PYROGEN TESTING MARKET SIZE, BY LIMULUS AMEBOCYTE LYSATE, 2017-2032 (USD MILLION)
TABLE 255. NATO PYROGEN TESTING MARKET SIZE, BY PYROGEN TYPE, 2017-2032 (USD MILLION)
TABLE 256. NATO PYROGEN TESTING MARKET SIZE, BY NON-ENDOTOXIN PYROGENS, 2017-2032 (USD MILLION)
TABLE 257. NATO PYROGEN TESTING MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 258. NATO PYROGEN TESTING MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 259. GLOBAL PYROGEN TESTING MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 260. UNITED STATES PYROGEN TESTING MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 261. UNITED STATES PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 262. UNITED STATES PYROGEN TESTING MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 263. UNITED STATES PYROGEN TESTING MARKET SIZE, BY KITS, 2017-2032 (USD MILLION)
TABLE 264. UNITED STATES PYROGEN TESTING MARKET SIZE, BY REAGENTS, 2017-2032 (USD MILLION)
TABLE 265. UNITED STATES PYROGEN TESTING MARKET SIZE, BY SERVICES, 2017-2032 (USD MILLION)
TABLE 266. UNITED STATES PYROGEN TESTING MARKET SIZE, BY TEST METHOD, 2017-2032 (USD MILLION)
TABLE 267. UNITED STATES PYROGEN TESTING MARKET SIZE, BY LIMULUS AMEBOCYTE LYSATE, 2017-2032 (USD MILLION)
TABLE 268. UNITED STATES PYROGEN TESTING MARKET SIZE, BY PYROGEN TYPE, 2017-2032 (USD MILLION)
TABLE 269. UNITED STATES PYROGEN TESTING MARKET SIZE, BY NON-ENDOTOXIN PYROGENS, 2017-2032 (USD MILLION)
TABLE 270. UNITED STATES PYROGEN TESTING MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 271. UNITED STATES PYROGEN TESTING MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 272. CANADA PYROGEN TESTING MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 273. CANADA PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 274. CANADA PYROGEN TESTING MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 275. CANADA PYROGEN TESTING MARKET SIZE, BY KITS, 2017-2032 (USD MILLION)
TABLE 276. CANADA PYROGEN TESTING MARKET SIZE, BY REAGENTS, 2017-2032 (USD MILLION)
TABLE 277. CANADA PYROGEN TESTING MARKET SIZE, BY SERVICES, 2017-2032 (USD MILLION)
TABLE 278. CANADA PYROGEN TESTING MARKET SIZE, BY TEST METHOD, 2017-2032 (USD MILLION)
TABLE 279. CANADA PYROGEN TESTING MARKET SIZE, BY LIMULUS AMEBOCYTE LYSATE, 2017-2032 (USD MILLION)
TABLE 280. CANADA PYROGEN TESTING MARKET SIZE, BY PYROGEN TYPE, 2017-2032 (USD MILLION)
TABLE 281. CANADA PYROGEN TESTING MARKET SIZE, BY NON-ENDOTOXIN PYROGENS, 2017-2032 (USD MILLION)
TABLE 282. CANADA PYROGEN TESTING MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 283. CANADA PYROGEN TESTING MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 284. MEXICO PYROGEN TESTING MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 285. MEXICO PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 286. MEXICO PYROGEN TESTING MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 287. MEXICO PYROGEN TESTING MARKET SIZE, BY KITS, 2017-2032 (USD MILLION)
TABLE 288. MEXICO PYROGEN TESTING MARKET SIZE, BY REAGENTS, 2017-2032 (USD MILLION)
TABLE 289. MEXICO PYROGEN TESTING MARKET SIZE, BY SERVICES, 2017-2032 (USD MILLION)
TABLE 290. MEXICO PYROGEN TESTING MARKET SIZE, BY TEST METHOD, 2017-2032 (USD MILLION)
TABLE 291. MEXICO PYROGEN TESTING MARKET SIZE, BY LIMULUS AMEBOCYTE LYSATE, 2017-2032 (USD MILLION)
TABLE 292. MEXICO PYROGEN TESTING MARKET SIZE, BY PYROGEN TYPE, 2017-2032 (USD MILLION)
TABLE 293. MEXICO PYROGEN TESTING MARKET SIZE, BY NON-ENDOTOXIN PYROGENS, 2017-2032 (USD MILLION)
TABLE 294. MEXICO PYROGEN TESTING MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 295. MEXICO PYROGEN TESTING MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 296. BRAZIL PYROGEN TESTING MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 297. BRAZIL PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 298. BRAZIL PYROGEN TESTING MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 299. BRAZIL PYROGEN TESTING MARKET SIZE, BY KITS, 2017-2032 (USD MILLION)
TABLE 300. BRAZIL PYROGEN TESTING MARKET SIZE, BY REAGENTS, 2017-2032 (USD MILLION)
TABLE 301. BRAZIL PYROGEN TESTING MARKET SIZE, BY SERVICES, 2017-2032 (USD MILLION)
TABLE 302. BRAZIL PYROGEN TESTING MARKET SIZE, BY TEST METHOD, 2017-2032 (USD MILLION)
TABLE 303. BRAZIL PYROGEN TESTING MARKET SIZE, BY LIMULUS AMEBOCYTE LYSATE, 2017-2032 (USD MILLION)
TABLE 304. BRAZIL PYROGEN TESTING MARKET SIZE, BY PYROGEN TYPE, 2017-2032 (USD MILLION)
TABLE 305. BRAZIL PYROGEN TESTING MARKET SIZE, BY NON-ENDOTOXIN PYROGENS, 2017-2032 (USD MILLION)
TABLE 306. BRAZIL PYROGEN TESTING MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 307. BRAZIL PYROGEN TESTING MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 308. UNITED KINGDOM PYROGEN TESTING MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 309. UNITED KINGDOM PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 310. UNITED KINGDOM PYROGEN TESTING MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 311. UNITED KINGDOM PYROGEN TESTING MARKET SIZE, BY KITS, 2017-2032 (USD MILLION)
TABLE 312. UNITED KINGDOM PYROGEN TESTING MARKET SIZE, BY REAGENTS, 2017-2032 (USD MILLION)
TABLE 313. UNITED KINGDOM PYROGEN TESTING MARKET SIZE, BY SERVICES, 2017-2032 (USD MILLION)
TABLE 314. UNITED KINGDOM PYROGEN TESTING MARKET SIZE, BY TEST METHOD, 2017-2032 (USD MILLION)
TABLE 315. UNITED KINGDOM PYROGEN TESTING MARKET SIZE, BY LIMULUS AMEBOCYTE LYSATE, 2017-2032 (USD MILLION)
TABLE 316. UNITED KINGDOM PYROGEN TESTING MARKET SIZE, BY PYROGEN TYPE, 2017-2032 (USD MILLION)
TABLE 317. UNITED KINGDOM PYROGEN TESTING MARKET SIZE, BY NON-ENDOTOXIN PYROGENS, 2017-2032 (USD MILLION)
TABLE 318. UNITED KINGDOM PYROGEN TESTING MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 319. UNITED KINGDOM PYROGEN TESTING MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 320. GERMANY PYROGEN TESTING MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 321. GERMANY PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 322. GERMANY PYROGEN TESTING MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 323. GERMANY PYROGEN TESTING MARKET SIZE, BY KITS, 2017-2032 (USD MILLION)
TABLE 324. GERMANY PYROGEN TESTING MARKET SIZE, BY REAGENTS, 2017-2032 (USD MILLION)
TABLE 325. GERMANY PYROGEN TESTING MARKET SIZE, BY SERVICES, 2017-2032 (USD MILLION)
TABLE 326. GERMANY PYROGEN TESTING MARKET SIZE, BY TEST METHOD, 2017-2032 (USD MILLION)
TABLE 327. GERMANY PYROGEN TESTING MARKET SIZE, BY LIMULUS AMEBOCYTE LYSATE, 2017-2032 (USD MILLION)
TABLE 328. GERMANY PYROGEN TESTING MARKET SIZE, BY PYROGEN TYPE, 2017-2032 (USD MILLION)
TABLE 329. GERMANY PYROGEN TESTING MARKET SIZE, BY NON-ENDOTOXIN PYROGENS, 2017-2032 (USD MILLION)
TABLE 330. GERMANY PYROGEN TESTING MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 331. GERMANY PYROGEN TESTING MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 332. FRANCE PYROGEN TESTING MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 333. FRANCE PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 334. FRANCE PYROGEN TESTING MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 335. FRANCE PYROGEN TESTING MARKET SIZE, BY KITS, 2017-2032 (USD MILLION)
TABLE 336. FRANCE PYROGEN TESTING MARKET SIZE, BY REAGENTS, 2017-2032 (USD MILLION)
TABLE 337. FRANCE PYROGEN TESTING MARKET SIZE, BY SERVICES, 2017-2032 (USD MILLION)
TABLE 338. FRANCE PYROGEN TESTING MARKET SIZE, BY TEST METHOD, 2017-2032 (USD MILLION)
TABLE 339. FRANCE PYROGEN TESTING MARKET SIZE, BY LIMULUS AMEBOCYTE LYSATE, 2017-2032 (USD MILLION)
TABLE 340. FRANCE PYROGEN TESTING MARKET SIZE, BY PYROGEN TYPE, 2017-2032 (USD MILLION)
TABLE 341. FRANCE PYROGEN TESTING MARKET SIZE, BY NON-ENDOTOXIN PYROGENS, 2017-2032 (USD MILLION)
TABLE 342. FRANCE PYROGEN TESTING MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 343. FRANCE PYROGEN TESTING MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 344. RUSSIA PYROGEN TESTING MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 345. RUSSIA PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 346. RUSSIA PYROGEN TESTING MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 347. RUSSIA PYROGEN TESTING MARKET SIZE, BY KITS, 2017-2032 (USD MILLION)
TABLE 348. RUSSIA PYROGEN TESTING MARKET SIZE, BY REAGENTS, 2017-2032 (USD MILLION)
TABLE 349. RUSSIA PYROGEN TESTING MARKET SIZE, BY SERVICES, 2017-2032 (USD MILLION)
TABLE 350. RUSSIA PYROGEN TESTING MARKET SIZE, BY TEST METHOD, 2017-2032 (USD MILLION)
TABLE 351. RUSSIA PYROGEN TESTING MARKET SIZE, BY LIMULUS AMEBOCYTE LYSATE, 2017-2032 (USD MILLION)
TABLE 352. RUSSIA PYROGEN TESTING MARKET SIZE, BY PYROGEN TYPE, 2017-2032 (USD MILLION)
TABLE 353. RUSSIA PYROGEN TESTING MARKET SIZE, BY NON-ENDOTOXIN PYROGENS, 2017-2032 (USD MILLION)
TABLE 354. RUSSIA PYROGEN TESTING MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 355. RUSSIA PYROGEN TESTING MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 356. ITALY PYROGEN TESTING MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 357. ITALY PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 358. ITALY PYROGEN TESTING MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 359. ITALY PYROGEN TESTING MARKET SIZE, BY KITS, 2017-2032 (USD MILLION)
TABLE 360. ITALY PYROGEN TESTING MARKET SIZE, BY REAGENTS, 2017-2032 (USD MILLION)
TABLE 361. ITALY PYROGEN TESTING MARKET SIZE, BY SERVICES, 2017-2032 (USD MILLION)
TABLE 362. ITALY PYROGEN TESTING MARKET SIZE, BY TEST METHOD, 2017-2032 (USD MILLION)
TABLE 363. ITALY PYROGEN TESTING MARKET SIZE, BY LIMULUS AMEBOCYTE LYSATE, 2017-2032 (USD MILLION)
TABLE 364. ITALY PYROGEN TESTING MARKET SIZE, BY PYROGEN TYPE, 2017-2032 (USD MILLION)
TABLE 365. ITALY PYROGEN TESTING MARKET SIZE, BY NON-ENDOTOXIN PYROGENS, 2017-2032 (USD MILLION)
TABLE 366. ITALY PYROGEN TESTING MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 367. ITALY PYROGEN TESTING MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 368. SPAIN PYROGEN TESTING MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 369. SPAIN PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 370. SPAIN PYROGEN TESTING MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 371. SPAIN PYROGEN TESTING MARKET SIZE, BY KITS, 2017-2032 (USD MILLION)
TABLE 372. SPAIN PYROGEN TESTING MARKET SIZE, BY REAGENTS, 2017-2032 (USD MILLION)
TABLE 373. SPAIN PYROGEN TESTING MARKET SIZE, BY SERVICES, 2017-2032 (USD MILLION)
TABLE 374. SPAIN PYROGEN TESTING MARKET SIZE, BY TEST METHOD, 2017-2032 (USD MILLION)
TABLE 375. SPAIN PYROGEN TESTING MARKET SIZE, BY LIMULUS AMEBOCYTE LYSATE, 2017-2032 (USD MILLION)
TABLE 376. SPAIN PYROGEN TESTING MARKET SIZE, BY PYROGEN TYPE, 2017-2032 (USD MILLION)
TABLE 377. SPAIN PYROGEN TESTING MARKET SIZE, BY NON-ENDOTOXIN PYROGENS, 2017-2032 (USD MILLION)
TABLE 378. SPAIN PYROGEN TESTING MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 379. SPAIN PYROGEN TESTING MARKET SIZE, BY

Companies Mentioned

  • BioMérieux SA
  • BMG LABTECH GmbH
  • Cambrex Corporation
  • Charles River Laboratories International, Inc.
  • Ellab A/S
  • Eurofins Scientific SE
  • Fujifilm Wako Pure Chemical Corporation
  • GenScript Biotech Corporation
  • Lonza Group AG
  • MAT BioTech BV
  • Merck KGaA
  • Microcoat Biotechnologie GmbH
  • Minerva Analytix GmbH
  • Nelson Laboratories LLC
  • Pacific BioLabs, Inc.
  • Sanquin Reagents B.V.
  • Sartorius AG
  • Seikagaku Corporation
  • Thermo Fisher Scientific Inc.
  • WuXi AppTec Co., Ltd.
  • Xiamen Bioendo Technology Co., Ltd.

Table Information

Report AttributeDetails
No. of Pages183
PublishedAugust 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 1.07 Billion
Forecasted Market Value ( USD ) by 2032 $ 1.96 Billion
Compound Annual Growth Rate10.4%
Regions CoveredGlobal
No. of Companies Mentioned21

Related Topics

Related Reports

Pyrogen Testing Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2032 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa) - Product Image

Pyrogen Testing Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2032 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

  • Report
  • 210 Pages
  • Global
From
Pyrogen and Endotoxin Testing Market Size, Share & Trends Analysis Report by Product, Technology, Application, End-Use, Region, and Growth Forecasts, 2026-2033 - Product Image

Pyrogen and Endotoxin Testing Market Size, Share & Trends Analysis Report by Product, Technology, Application, End-Use, Region, and Growth Forecasts, 2026-2033

  • Report
  • 140 Pages
  • Global
From
Pyrogen Testing Market Report by Product, Test Type, Application, and Region 2026-2034 - Product Image

Pyrogen Testing Market Report by Product, Test Type, Application, and Region 2026-2034

  • Report
  • 139 Pages
  • Global
From
Pyrogen Testing Market Report 2026 - Product Image

Pyrogen Testing Market Report 2026

  • Report
  • 250 Pages
  • Global
From
Monocyte Activation Tests Market - Product Image

Monocyte Activation Tests Market

  • Report
  • 150 Pages
  • Global
From

About the Pyrogen Test Market

The Pyrogen Test is a type of infectious disease testing used to detect the presence of pyrogens, which are substances that cause fever. It is used to detect the presence of bacterial toxins, endotoxins, and other pyrogens in a variety of biological samples. The test is used to ensure the safety of pharmaceuticals, medical devices, and other products that come into contact with the human body. It is also used to detect the presence of pyrogens in water, food, and other environmental samples. The Pyrogen Test market is composed of a variety of companies that provide testing services and products. These include companies such as Bio-Rad Laboratories, Charles River Laboratories, Lonza Group, Merck KGaA, and Thermo Fisher Scientific. Show Less Read more

Copyright © 2002-2026 Research and Markets. All Rights Reserved.